PixCell Medical, an innovator of rapid hematology testing solutions at the point of care, has developed the only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use – the HemoScreen™. This portable, easy-to-use platform offers clinically proven lab-accurate readings of 20 standard blood count parameters within five minutes, with just one finger-prick of blood. This facilitates fast diagnostic results and data-driven disease management decisions.
Leveraging a cutting-edge disposable cartridge preloaded with all necessary reagents, HemoScreen’s unique AI-powered Viscoelastic Focusing technology enables improved medical outcomes and patient quality of life while substantially reducing costs for healthcare providers.
Brands: HemoScreen™